Cite

    Wang, Z., Huang, C., Yang, J., Song, Y., Cheng, Y., Chen, G., Yan, H., Ben, X., Wang, B., Xu, C., Jiang, B., Zhou, Q., Chen, H., & Wu, Y. (2019). a randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). European journal of cancer, 109, 183–191. http://access.bl.uk/ark:/81055/vdc_100083884287.0x000023